1,650
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Discovery of potential SARS-CoV 3CL protease inhibitors from approved antiviral drugs using: virtual screening, molecular docking, pharmacophore mapping evaluation and dynamics simulation

, , , &
Pages 12574-12591 | Received 09 Feb 2021, Accepted 23 Aug 2021, Published online: 20 Sep 2021

References

  • Abouelela, M. E., Assaf, H. K., Abdelhamid, R. A., Elkhyat, E. S., Sayed, A. M., Oszako, T., Belbahri, L., El Zowalaty, A. E., & Abdelkader, M. S. A. (2021). Identification of potential SARS-CoV-2 main protease and spike protein inhibitors from the genus aloe: An in silico study for drug development. Molecules, 26(6), 1767. https://doi.org/10.3390/molecules26061767
  • Alamri, M. A., Tahir Ul Qamar, M., & Alqahtani, S. M. (2020). Pharmacoinformatics and molecular dynamic simulation studies reveal potential inhibitors of SARS-CoV-2 main protease 3CLpro. Journal of Biomolecular Structure and Dynamics, 39(13), 4936-4948. https://doi.org/10.1080/07391102.2020.1782768
  • Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006). The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics (Oxford, England), 22(2), 195–201. https://doi.org/10.1093/bioinformatics/bti770
  • Aryapour, H., Dehdab, M., Sohraby, F., & Bargahi, A. (2017). Prediction of new chromene-based inhibitors of tubulin using structure-based virtual screening and molecular dynamics simulation methods. Computational Biology and Chemistry, 71, 89–97. https://doi.org/10.1016/j.compbiolchem.2017.09.007
  • Azam, M. A., & Jupudi, S. (2017). Extra precision docking, free energy calculation and molecular dynamics studies on glutamic acid derivatives as MurD inhibitors. Computational Biology and Chemistry, 69, 55–63. https://doi.org/10.1016/j.compbiolchem.2017.05.004
  • Ballu, S., Itteboina, R., Sivan, S. K., & Manga, V. (2018). Rational design of methicillin resistance staphylococcus aureus inhibitors through 3D-QSAR, molecular docking and molecular dynamics simulations. Computational Biology and Chemistry, 73, 95–104. https://doi.org/10.1016/j.compbiolchem.2017.12.007
  • Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., … Lane, H. C. (2020). Remdesivir for the treatment of Covid-19. New England Journal of Medicine, 383(19), 1813–1826. https://doi.org/10.1056/NEJMoa2007764
  • Berendsen, H. J., Postma, J. V., van Gunsteren, W. F., DiNola, A. R., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
  • Bond, S. D., Benedict, J. L., & Laird, B. B. (1999). The Nosé-Poincaré Method for Constant Temperature Molecular Dynamics. Journal of Computational Physics, 151(1), 114–134. https://doi.org/10.1006/jcph.1998.6171
  • Bosch, B. J., van der Zee, R., de Haan, C. A., & Rottier, P. J. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. Journal of Virology, 77(16), 8801–8811. https://doi.org/10.1128/jvi.77.16.8801-8811.2003
  • Bourouiba, L. (2020). Turbulent gas clouds and respiratory pathogen emissions: Potential implications for reducing transmission of COVID-19. JAMA, 323(18), 1837-1838. https://doi.org/10.1001/jama.2020.4756
  • Bullard-Feibelman, K. M., Govero, J., Zhu, Z., Salazar, V., Veselinovic, M., Diamond, M. S., & Geiss, B. J. (2017). The FDA-approved drug sofosbuvir inhibits Zika virus infection. Antiviral Research, 137, 134–140. https://doi.org/10.1016/j.antiviral.2016.11.023
  • Calina, D., Docea, A. O., Petrakis, D., Egorov, A. M., Ishmukhametov, A. A., Gabibov, A. G., Shtilman, M. I., Kostoff, R., Carvalho, F., Vinceti, M., Spandidos, D. A., & Tsatsakis, A. (2020). Towards effective COVID‐19 vaccines: Updates, perspectives and challenges (Review). International Journal of Molecular Medicine, 46(1), 3–16. https://doi.org/10.3892/ijmm.2020.4596
  • Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., Hayden, F. G., & Yuen, K.-Y. (2013). Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. The Journal of Infection, 67(6), 606–616. https://doi.org/10.1016/j.jinf.2013.09.029
  • Chaube, U., Chhatbar, D., & Bhatt, H. (2016). 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer. Bioorganic & Medicinal Chemistry Letters, 26(3), 864–874. https://doi.org/10.1016/j.bmcl.2015.12.075
  • Chen, K. C., Chen, H. Y., & Chen, C. Y. C. (2014). Potential protein phosphatase 2A agents from traditional Chinese medicine against cancer. Evidence-Based Complementary and Alternative Medicine, 2014, 436–863.
  • Chen, Y. C. (2015). Beware of docking!. Trends in Pharmacological Sciences, 36(2), 78–95. https://doi.org/10.1016/j.tips.2014.12.001
  • Chenafa, H., Mesli, F., Daoud, I., Achiri, R., Ghalem, S., & Neghra, A. (2021). In silico design of enzyme α-amylase and α-glucosidase inhibitors using molecular docking, molecular dynamic, conceptual DFT investigation and pharmacophore modelling. Journal of Biomolecular Structure and Dynamics, 39, 1–22.
  • Choudhary, M. I., Shaikh, M., Tul-Wahab, A., & Ur-Rahman, A. (2020). In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. PLOS One, 15(7), e0235030. https://doi.org/10.1371/journal.pone.0235030
  • Clément, G., & Slenzka, K. (2006). Fundamentals of space biology: Research on cells, animals, and plants in space. Springer.
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
  • Dal Ben, D., Buccioni, M., Lambertucci, C., Thomas, A., & Volpini, R. (2013). Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor. In Silico Pharmacology, 1(1), 24. https://doi.org/10.1186/2193-9616-1-24
  • Daoud, I., Melkemi, N., Salah, T., & Ghalem, S. (2018). Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors. Computational Biology and Chemistry, 74, 304–326. https://doi.org/10.1016/j.compbiolchem.2018.03.021
  • de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014). Screening of an FDA-approved compound library identifies four small-molecule inhibitors of middle east respiratory syndrome coronavirus replication in cell culture. Antimicrobial Agents and Chemotherapy, 58(8), 4875–4884. https://doi.org/10.1128/AAC.03011-14
  • Delaney, J. S. (2005). Predicting aqueous solubility from structure. Drug Discovery Today, 10(4), 289–295. https://doi.org/10.1016/S1359-6446(04)03365-3
  • Didierjean, C., & Tête-Favier, F. (2016). Introduction to protein science. In Architecture, function and genomics (3rd ed., 466p, A. M. Lesk, Eds.). Oxford University Press. ISBN 9780198716846.
  • Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10–11), 647–671. https://doi.org/10.1007/s10822-006-9087-6
  • Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., Johansen, L. M., Lear-Rooney, C. M., Glass, P. J., Hensley, L. E., & Frieman, M. B. (2014). Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy, 58(8), 4885–4893. https://doi.org/10.1128/AAC.03036-14
  • Ekins, S., Ecker, G. F., Chiba, P., & Swaan, P. W. (2007). Future directions for drug transporter modelling. Xenobiotica; The Fate of Foreign Compounds in Biological Systems, 37(10–11), 1152–1170. https://doi.org/10.1080/00498250701646341
  • Fagerholm, U. (2007). Prediction of human pharmacokinetics-gastrointestinal absorption. The Journal of Pharmacy and Pharmacology, 59(7), 905–916. https://doi.org/10.1211/jpp.59.7.0001
  • Furuta, Y., Takahashi, K., Kuno-Maekawa, M., Sangawa, H., Uehara, S., Kozaki, K., Nomura, N., Egawa, H., & Shiraki, K. (2005). Mechanism of action of T-705 against influenza virus. Antimicrobial Agents and Chemotherapy, 49(3), 981–986. https://doi.org/10.1128/AAC.49.3.981-986.2005
  • Gao, J., Zhenxue, T., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends, 14(1), 72-73. https://doi.org/10.5582/bst.2020.01047
  • Gautret, P., Lagier, J. C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., Tissot Dupont, H., Honoré, S., Colson, P., Chabrière, E., La Scola, B., Rolain, J. M., Brouqui, P., & Raoult, D. (2020). Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 56(1), 105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
  • Guex, N., Peitsch, M. C., & Schwede, T. (2009). Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective. Electrophoresis, 30(S1), S162–S173. https://doi.org/10.1002/elps.200900140
  • Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5–6), 490–519. [Database] https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
  • Halgren, T. A. (1999). MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries. Journal of Computational Chemistry, 20(7), 730–748. https://doi.org/10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T
  • Hernández-Rodríguez, M., Correa-Basurto, J., Gutiérrez, A., Vitorica, J., & Rosales-Hernández, M. C. (2016). Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations. European Journal of Medicinal Chemistry, 124, 1142–1154. https://doi.org/10.1016/j.ejmech.2016.08.028
  • Hevener, K. E., Zhao, W., Ball, D. M., Babaoglu, K., Qi, J., White, S. W., & Lee, R. E. (2009). Validation of molecular docking programs for virtual screening against dihydropteroate synthase. Journal of Chemical Information and Modeling, 49(2), 444–460. https://doi.org/10.1021/ci800293n
  • Hou, T. J., Li, Y. Y., & Zhang, W. (2008). Recent developments of in silico predictions of intestinal absorption and oral bioavailability. Combinatorial Chemistry & High Throughput Screening, 12(5), 497-506. https://doi.org/10.2174/138620709788489082
  • Hou, T., Wang, J., Zhang, W., Wang, W., & Xu, X. (2006). Recent advances in computational prediction of drug absorption and permeability in drug discovery. Current Medicinal Chemistry, 13(22), 2653–2667. https://doi.org/10.2174/092986706778201558
  • Huang, H. J., Lee, C. C., & Chen, C. Y. C. (2014). Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine. BioMed Research International, 2014, 764946. https://doi.org/10.1155/2014/764946
  • Hung, T. C., Lee, W. Y., Chen, K. B., Chan, Y. C., Lee, C. C., & Chen, C. Y. C. (2014). In silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer's disease. BioMed Research International, 2014, 769867–769867. https://doi.org/10.1155/2014/769867
  • HyperChem v8. (2009). Molecular modelling system. Hypercube Inc.
  • Imberty, A., Hardman, K. D., Carver, J. P., & Perez, S. (1991). Molecular modelling of protein-carbohydrate interactions. Docking of monosaccharides in the binding site of concanavalin A. Glycobiology, 1(6), 631–642. https://doi.org/10.1093/glycob/1.6.631
  • Jaworski, J. S., Bankiewicz, B., Krygowski, T. M., Palusiak, M., Stasyuk, O. A., & Szatylowicz, H. (2016). Interactions of polar hydrogen bond donor solvents with ions: A theoretical study. Structural Chemistry, 27(4), 1279–1289. https://doi.org/10.1007/s11224-016-0769-y
  • Johnson, S. R., & Zheng, W. F. (2006). Recent progress in the computational prediction of aqueous solubility and absorption. The AAPS Journal, 8(1), E27–40. https://doi.org/10.1208/aapsj080104
  • Jolivette, L. J., & Ekins, S. (2007). Methods for predicting human drug metabolism. Advances in Clinical Chemistry, 43, 131–176. https://doi.org/10.1016/s0065-2423(06)43005-5
  • Jones, I., & Roy, P. (2021). Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet (London, England), 397(10275), 642–643. https://doi.org/10.1016/S0140-6736(21)00191-4
  • Keyaerts, E., Vijgen, L., Maes, P., Neyts, J., & Van Ranst, M. (2004). In vitro inhibition of severe acute respiratory syndrome coronavirus by Chloroquine. Biochemical and Biophysical Research Communications, 323(1), 264–268. https://doi.org/10.1016/j.bbrc.2004.08.085
  • Kiefer, F., Arnold, K., Künzli, M., Bordoli, L., & Schwede, T. (2009). The SWISS-MODEL Repository and associated resources. Nucleic Acids Research, 37(Issue suppl_1), D387–D392. https://doi.org/10.1093/nar/gkn750
  • Klebe, G. (2006). Virtual ligand screening: Strategies, perspectives and limitations. Drug Discovery Today, 11(13–14), 580–594. https://doi.org/10.1016/j.drudis.2006.05.012
  • Kleywegt, G. J., & Jones, T. A. (1997). [11] Model building and refinement practice. Methods in Enzymology, 277, 208–230.
  • Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005). Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences of the United States of America, 102(39), 14040–14045. https://doi.org/10.1073/pnas.0506735102
  • Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews. Drug Discovery, 19(5), 305–306. https://doi.org/10.1038/d41573-020-00073-5
  • Lee, C. Y.-P., Lin, R. T. P., Renia, L., & Ng, L. F. P. (2020). Serological approaches for COVID-19: Epidemiologic perspective on surveillance and control. Frontiers in Immunology, 11, 879. https://doi.org/10.3389/fimmu.2020.00879
  • Lee, J. S., & Shin, E.-C. (2020). The type I interferon response in COVID-19: Implications for treatment. Nature Reviews Immunology, 20(10), 585–586. https://doi.org/10.1038/s41577-020-00429-3
  • Liu, X., Ouyang, S., Yu, B., Liu, Y., Huang, K., Gong, J., Zheng, S., Li, Z., Li, H., & Jiang, H. (2010). PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Research, 38(Web Server issue), W609–W614. https://doi.org/10.1093/nar/gkq300
  • Livingston, E. H., Malani, P. N., & Creech, C. B. (2021). The Johnson & Johnson vaccine for COVID-19. JAMA, 325(15), 1575–1575. https://doi.org/10.1001/jama.2021.2927
  • Luiz, C. S., Pinheiro, L., M Feitosa, L., O Gandi, M., F Silveira, F., & Boechat, N. (2019). The development of novel compounds against malaria: Quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines. Molecules, 24(22), 4095. https://doi.org/10.3390/molecules24224095
  • Mahase, E. (2020). Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows. BMJ: British Medical Journal, 371, 4347. https://doi.org/10.1136/bmj.m4471.
  • Mani, D., Wadhwani, A., & Krishnamurthy, P. T. (2019). Drug repurposing in antiviral research: A current scenario. Journal of Young Pharmacists, 11(2), 117–121. https://doi.org/10.5530/jyp.2019.11.26
  • Marechal, Y. (2007). The hydrogen bond and the water molecule: The physics and chemistry of water, aqueous, and bio-media. Elsevier.
  • McChesney, E. W. (1983). Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. The American Journal of Medicine, 75(1A), 11–18. https://doi.org/10.1016/0002-9343(83)91265-2
  • Mesli, F., Daoud, I., & Ghalem, S. (2019). Antidiabetic activity of Nigella Sativa (BLACK SEED)-by molecular modeling elucidation, molecular dynamic, and conceptual DFT investigation. Pharmacophore, 10(5), 57–66.
  • Mesli, F., Ghalem, M., Daoud, I., & Ghalem, S. (2021). Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping. Journal of Biomolecular Structure and Dynamics, 39, 1–13.
  • Molecular Operating Environment (Moe). (2019)., 2013.08; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, H3a 2r7.
  • Müller, L., Andrée, M., Moskorz, W., Drexler, I., Walotka, L., Grothmann, R., Ptok, J., Hillebrandt, J., Ritchie, A., Rabl, D. and Ostermann, P.N., Robitzsch, R., Hauka, S., Walker, A., Menne, C., Grutza, R., Timm, J., Adams, O., Schaal, H. (2021). Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination. Clin Infect Dis., ciab381. https://doi.org/10.1093/cid/ciab381. Epub ahead of print. PMID: 33906236; PMCID: PMC8135422.
  • Nadia, B., Mesli, F., Zahra, B. F., Merad-Boussalah, N., Radja, A., Muselli, A., Djabou, N., & Dib, M. E. A. (2020). Chemical composition variability and vascular endothelial growth factor receptors inhibitory activity of Inulaviscosa essential oils from Algeria. Journal of Biomolecular Structure and Dynamics, 39, 1–19.
  • Narkhede, R. R., Cheke, R. S., Ambhore, J. P., & Shinde, S. D. (2020). The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2. Eurasian Journal of Medicine and Oncology, 4(3), 185–195.
  • National Institutes of Health (NIH). (2020). 17 March "New coronavirus stable for hours on surfaces". Retrieved 24 March 2020.
  • Norinder, U., & Bergstrom, C. A. S. (2006). Prediction of ADMET properties. ChemMedChem, 1(9), 920–937. https://doi.org/10.1002/cmdc.200600155
  • Norinder, U., & Haeberlein, M. (2002). Computational approaches to the prediction of the blood-brain distribution. Advanced Drug Delivery Reviews, 54(3), 291–313. https://doi.org/10.1016/S0169-409X(02)00005-4
  • Omrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014). Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study. The Lancet Infectious Diseases, 14(11), 1090–1095. https://doi.org/10.1016/S1473-3099(14)70920-X
  • Palacios, R., Patiño, E. G., de Oliveira Piorelli, R., Conde, M. T. R. P., Batista, A. P., Zeng, G., Xin, Q., Kallas, E. G., Flores, J., Ockenhouse, C. F., & Gast, C. (2020). Double-blind, randomized, placebo-controlled phase iii clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(1), 853–853. https://doi.org/10.1186/s13063-020-04775-4
  • Panisheva, E. K., Mikerova, N. I., Nikolaeva, I. S., Fomina, A. N., Cherkasova, A. A., Golovanova, E. A., & Krylova, L. Y. (1988). Synthesis and antiviral activity of 5-oxyindole derivatives. Pharmaceutical Chemistry Journal, 22, 901–904.1
  • Parr, R. G. & Yang, W. (1980). Density functional theory of atoms and molecules (Vol. 1, 989p). Oxford University Press.
  • Reusken, C. B. E. M., Haagmans, B. L., Müller, M. A., Gutierrez, C., Godeke, G.-J., Meyer, B., Muth, D., Raj, V. S., Smits-De Vries, L., Corman, V. M., Drexler, J.-F., Smits, S. L., El Tahir, Y. E., De Sousa, R., van Beek, J., Nowotny, N., van Maanen, K., Hidalgo-Hermoso, E., Bosch, B.-J., … Koopmans, M. P. G. (2013). Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. The Lancet Infectious Diseases, 13(10), 859–866. https://doi.org/10.1016/S1473-3099(13)70164-6
  • Robertson, C. C., Wright, J. S., Carrington, E. J., Perutz, R. N., Hunter, C. A., & Brammer, L. (2017). Hydrogen bonding vs. halogen bonding: The solvent decides. Chemical Science, 8(8), 5392–5398. https://doi.org/10.1039/c7sc01801k
  • Rosales-Mendoza, S., MáRquez-Escobar, V. A., & GonzáLez-Ortega, O. (2020). What does plant-based vaccine technology offer to the fight against COVID-19? Vaccines, 8, 183. https://doi.org/10.3390/vaccines8020183
  • Ryzhikov, A. B., Ryzhikov, Е. А., Bogryantseva, M. P., Usova, S. V., Danilenko, E. D., Nechaeva, E. A., Pyankov, O. V., Pyankova, O. G., Gudymo, A. S., Bodnev, S. A., Onkhonova, G. S., Sleptsova, E. S., Kuzubov, V. I., Ryndyuk, N. N., Ginko, Z. I., Petrov, V. N., Moiseeva, A. A., Torzhkova, P. Y., Pyankov, S. A., … Maksyutov, R. A. (2021). A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I-II). Russian Journal of Infection and Immunity, 11(2), 283–296. https://doi.org/10.15789/2220-7619-ASB-1699
  • Sakurai, Y., Kolokoltsov, A. A., Chen, C.-C., Tidwell, M. W., Bauta, W. E., Klugbauer, N., Grimm, C., Wahl-Schott, C., Biel, M., & Davey, R. A. (2015). Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science (New York, NY), 347(6225), 995–998. https://doi.org/10.1126/science.1258758
  • Silva, T. B., Bernardino, A. M., Maria de Lourdes, G. F., Rogerio, K. R., Carvalho, L. J., Boechat, N., & Pinheiro, L. C. (2016). Design, synthesis and anti-P. falciparum activity of pyrazolopyridine-sulfonamide derivatives. Bioorganic & Medicinal Chemistry, 24(18), 4492–4498. https://doi.org/10.1016/j.bmc.2016.07.049
  • Stewart, J. J. P. (2007). Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements. Journal of Molecular Modeling, 13(12), 1173–1213. https://doi.org/10.1007/s00894-007-0233-4
  • Sturgeon, J. B., & Laird, B. B. (2000). Symplectic algorithm for constant-pressure molecular-dynamics using a Nose-Poincare thermostat. Journal of Chemical Physics, 112(8), 3474–3482. https://doi.org/10.1063/1.480502
  • Thomsen, R., & Christensen, M. H. (2006). MolDock: A new technique for high-accuracy molecular docking. Journal of Medicinal Chemistry, 49(11), 3315–3321. https://doi.org/10.1021/jm051197e
  • Van De Waterbeemd, H., & Gifford, E. (2003). ADMET in silico modelling: Towards prediction paradise? Nature Reviews. Drug Discovery, 2(3), 192–204. https://doi.org/10.1038/nrd1032
  • Varadwaj, P. R., Varadwaj, A., Marques, H. M., & Yamashita, K. (2019). Significance of hydrogen bonding and other noncovalent interactions in determining octahedral tilting in the CH3NH3PbI3 hybrid organic-inorganic halide perovskite solar cell semiconductor. Scientific Reports, 9(1), 50–29. https://doi.org/10.1038/s41598-018-36218-1
  • Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005). Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal, 2, 69. https://doi.org/10.1186/1743-422X-2-69
  • Wang, X., Pan, C., Gong, J., Liu, X., & Li, H. (2016). Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs. Journal of Chemical Information and Modeling, 56(6), 1175–1183. https://doi.org/10.1021/acs.jcim.5b00690
  • Wang, X., Shen, Y., Wang, S., Li, S., Zhang, W., Liu, X., Lai, L., Pei, J., & Li, H. (2017). PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Research, 45(W1), W356–W360. https://doi.org/10.1093/nar/gkx374
  • Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., Hu, Y., Luo, G., Wang, K., Lu, Y., Li, H., Wang, S., Ruan, S., Yang, C., Mei, C., … Wang, C. (2020). Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebocontrolled, multicentre trial. The Lancet, 395(10236), 1569–1578. https://doi.org/10.1016/S0140-6736(20)31022-9
  • Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., Larson, N., Strickley, R., Wells, J., Stuthman, K. S., Van Tongeren, S. A., Garza, N. L., Donnelly, G., Shurtleff, A. C., Retterer, C. J., … Bavari, S. (2016). Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature, 531(7594), 381–385. https://doi.org/10.1038/nature17180
  • Wise, J. (2021). Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ (Clinical Research ed.), 372, n699. https://doi.org/10.1136/bmj.n699
  • Witkowski, J. T., Robins, R. K., Sidwell, R. W., & Simon, L. N. (1972). Design, synthesis, and broad spectrum antiviral activity of 1-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. Journal of Medicinal Chemistry, 15(11), 1150–1154. https://doi.org/10.1021/jm00281a014
  • Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 10(5), 766–788. https://doi.org/10.1016/j.apsb.2020.02.008
  • Xie, N. Z., Du, Q. S., Li, J. X., & Huang, R. B. (2015). Exploring strong interactions in proteins with quantum chemistry and examples of their applications in drug design. PLoS One, 10(9), e0137113. https://doi.org/10.1371/journal.pone.0137113
  • Xu, M., Zhang, B., Wang, Q., Yuan, Y., Sun, L., & Huang, Z. (2018). Theoretical study on the hydrogen bonding interactions in paracetamol-water complexes. Journal of the Chilean Chemical Society, 63(1), 3788–3794. https://doi.org/10.4067/s0717-97072018000103788
  • Zaretzki, J., Bergeron, C., Huang, T. W., Rydberg, P., Swamidass, S. J., & Breneman, C. M. (2013). RS-WebPredictor: A server for predicting CYP-mediated sites of metabolism on drug-like molecules. Bioinformatics (Oxford, England), 29(4), 497–498. https://doi.org/10.1093/bioinformatics/bts705
  • Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S., & Yuen, K. Y. (2016). Coronaviruses - drug discovery and therapeutic options. Nature Reviews. Drug Discovery, 15(5), 327–347. https://doi.org/10.1038/nrd.2015.37

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.